Research
Hormonal
Physiological concentrations of fasting plasma adiponectin do not play a role in the regulation of whole-body fat oxidation or energy expenditure in resting conditions.
Adiponectin may not be a target for increasing fat oxidation or energy expenditure in healthy individuals.
StrongRefutesmedium confidence
Our cross-sectional data do not suggest physiological concentrations of fasting plasma adiponectin play a role in the regulation of whole-body fat oxidation or energy expenditure in resting conditions.
Why this rating
Based on study design from abstract.
Source
Plasma Adiponectin Levels Are Not Associated with Fat Oxidation in Humans
Norbert Stefan et al. · Obesity Research · 2002
DOI 10.1038/oby.2002.138
cross-sectional · n=93Cited 44×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →